Detail of the clinical trial

Title of the trial A Phase 2 Study of Inotuzumab Ozogamicin (INO) Combined to Chemotherapy in Older Patients with Philadelphia Chromosome-negative CD22+ B-cell Precursor Acute Lymphoblastic Leukemia
EudraCT number 2016-004942-27
Protocol number P16/11
Sponsor Centre Hospitalier de Versailles,177 rue de Versailles, 78157 Le Chesnay Cedex, France
Indications Hemato-oncology
Diagnosis Lymphoblastic Leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2018
Date of approval by Institute (SÚKL) 13.3.2018
Date of approval by EC
Date of initiation CT in ČR 9.5.2019
Date of ending CT in ČR
Notice
Sites Fakultní nemocnice Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno,625 00
Ústav hematologie a krevní transfuze,Klinický úsek,U Nemocnice 2094/1,Praha 2,128 20

‹‹ Back to list